Rucaparib for the Treatment of Metastatic Castration-resistant Prostate Cancer Associated with a DNA Damage Repair Gene Alteration: Final Results from the Phase 2 TRITON2 Study
Wassim Abida(Memorial Sloan Kettering Cancer Center), David Campbell(Barwon Health), Akash Patnaik(University of Chicago), Alan H. Bryce(Mayo Clinic Hospital), Jeremy Shapiro(Cabrini Hospital), Richard Bambury(Cork University Hospital), Jingsong Zhang(Moffitt Cancer Center), John M. Burke(Rocky Mountain Cancer Centers), Daniel Castellano(Research Institute Hospital 12 de Octubre), Albert Font(Institut Català d'Oncologia), Vinod Ganju(Hudson Institute of Medical Research), Anne‐Claire Hardy‐Bessard, Ray McDermott(Tallaght University Hospital), Brieuc Sautois(Centre Hospitalier Universitaire de Liège), Dominique Spaëth(Centre d’Investigation Clinique Innovation Technologique de Nancy), Éric Voog(Centre Jean Bernard), Josep M. Piulats(Institut Català d'Oncologia), Elias Pintus(Guy's and St Thomas' NHS Foundation Trust), Charles J. Ryan(University of Minnesota), Axel S. Merseburger(University Hospital Schleswig-Holstein), Gedske Daugaard(Copenhagen University Hospital), Axel Heidenreich(University of Cologne), Karim Fizazi(Université Paris-Saclay), Andrea Loehr(Clovis Oncology (United States)), Darrin Despain(Clovis Oncology (United States)), Andrew D. Simmons(Clovis Oncology (United States)), Melanie Dowson(Clovis Oncology (United Kingdom)), Jowell Go(Clovis Oncology (United States)), Simon P. Watkins(Clovis Oncology (United Kingdom)), Simon Chowdhury(Guy's and St Thomas' NHS Foundation Trust)
Cited by 92Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis